Stem cell factor: Began Phase III trial in combination with Neupogen

Amgen Inc. (AMGN), Thousand Oaks, Calif. Product: Stem cell factor ( SCF) Indication: Mobilize progenitor cells in cancer treatment Status: Began Phase III trial in combination with Neupogen ...